Ceribell is a medical device company founded in 2010 and headquartered in San Francisco that specializes in seizure detection for hospitalized and critically ill patients. The company developed the Ceribell Alert Monitor, a portable EEG-based device designed to continuously monitor for non-convulsive seizures in ICU and hospital settings. Ceribell went public on NASDAQ in March 2021. The company addresses a significant clinical need: many seizures in critically ill patients are non-convulsive and cannot be reliably identified through clinical observation alone, making continuous EEG monitoring essential. Ceribell's technology helps clinicians detect seizure activity earlier, enabling faster intervention and improved patient outcomes in acute care environments where seizure detection capabilities are often limited.
45 open now, 45 first appeared in the last 30d.